Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 2021

View Archived Issues

Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance

New triglyceride-mimetic structure-gated prodrug nanoplatform for precise tumor drug delivery

Red seaweed-derived iota-carrageenan shows in vitro activity against SARS-CoV-2 and VOCs

Boehringer Ingelheim, Vanderbilt University describe mutant GTPase KRAS inhibitors

New RIPK1 inhibitors discovered at Sanofi

New USP30 inhibitors identified at Mission Therapeutics

TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators

Roche identifies new antibacterials

Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia

Blocking PAI-1 inhibits experimental PTSD development

Changing splicing lowers mutant Huntingtin

Sequential immunization strategy for HIV-1 yields off-target effects and low protection in macaques

Multiclade env-gag VLP mRNA vaccine is safe, immunogenic and protects macaques from SHIV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...